VB2-32664-13855
5 vaccinations
2 coded responses
51 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 208 / MD
- Registered
- 2021-03-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-17
Registered in v-safe
-
2021-03-17
Dose 1 — Pfizer-BioNTech
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-31
-
2021-04-07
Dose 2 — Pfizer-BioNTech
- 2021-04-07
-
2021-04-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-05-12
- 2021-05-19
- 2021-07-07
- 2021-10-07
-
2021-12-05
Dose 3 — Pfizer-BioNTech
- 2021-12-05
-
2021-12-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fever · Headache, NauseaAdult check-in
-
2021-12-08
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain — Feeling: GoodFree text: Pain in nodes in armpit of arm where received shotMedDRA releases: 2024-11 · check-in free text available
- 2021-12-09
- 2021-12-10
- 2021-12-11
- 2021-12-12
- 2021-12-19
- 2021-12-26
- 2022-01-02
- 2022-01-09
- 2022-01-16
- 2022-03-07
-
2022-05-21
Dose 4 — Moderna
-
2022-05-22
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-05-23
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Redness · Headache, Fatigue or tirednessAdult check-in
- 2022-05-24
- 2022-05-26
- 2022-05-27
- 2022-05-28
- 2022-06-04
- 2022-06-11
- 2022-06-20
- 2022-06-25
- 2022-07-02
-
2022-08-20
Survey response — 3 months, dose 4MedDRA: Diarrhoea, Nausea, Oropharyngeal pain, Pyrexia, Respiratory tract congestion, Vomiting — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: nausea vomiting diarrhea congestion sore throat feverMedDRA releases: 2024-11 · check-in free text available
-
2022-08-20
Report sent to call center — 3 months, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-08-22
-
2022-11-26
Dose 5 — Pfizer-BioNTech
- 2023-05-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-17 | Pfizer-BioNTech | |
| 2 | 2021-04-07 | Pfizer-BioNTech | |
| 3 | 2021-12-05 | Pfizer-BioNTech | No |
| 4 | 2022-05-21 | Moderna | No |
| 5 | 2022-11-26 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-08-20 | Unsuccessful |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Pain in nodes in armpit of arm where received shot
Release 12 — 3 months, dose 4
Symptoms: nausea vomiting diarrhea congestion sore throat fever
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Lymph node pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release